Results 121 to 130 of about 389,425 (138)

Biomarker enrichment strategies: matching trial design to biomarker credentials

Nature Reviews Clinical Oncology, 2013
Boris Freidlin
exaly  

MAIA under the microscope — bringing trial design into focus

Nature Reviews Clinical Oncology, 2019
Prashant Kapoor, S Vincent Rajkumar
exaly  

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Lancet, The, 2016
Ian J Jacobs, Usha Menon, Andy Ryan
exaly  

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Lancet, The, 2012
Peter Sandercock, Joanna M Wardlaw, Richard I Lindley   +2 more
exaly  

Clinical Trial Registration

Archives of Internal Medicine, 2006
  +4 more sources

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

Lancet, The, 2008
Homer Yang, Gordon Guyatt, Kate Leslie
exaly  

Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial

Lancet, The, 2016
Rajesh Patel, Janet T Powell
exaly  

Cancer therapy and the randomized clinical trial: good medicine?

Ca-A Cancer Journal for Clinicians, 1994
exaly  

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

Lancet, The, 2010
Hans Erik Bøtker, Morten Bøttcher, Kim Munk   +2 more
exaly  

NIH tackles clinical trial shortcomings

Nature Reviews Drug Discovery, 2016
exaly